MyAverix Finance
TWO · Healthcare
Sagittarius Life Science (3205)
Biotechnology
Sagittarius Life Science (3205) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3205
Sagittarius Life Science (3205) — FAQ
What is 3205's P/E ratio?
The price-to-earnings (P/E) ratio for Sagittarius Life Science (3205) is 25.00 (data as of 2026-05-23).
Does Sagittarius Life Science pay a dividend?
Dividend yield is not available in the current snapshot for Sagittarius Life Science (3205). Check the MyAverix Finance app for the latest dividend data.
What sector is Sagittarius Life Science in?
Sagittarius Life Science (3205) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 3205 listed on?
3205 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.